local_hospital

Fakultni Nemocnice Brno

Address
lock Available on a paid plan

Cardiovascular Research at Fakultni Nemocnice Brno

Clinical trials in cardiovascular diseases focus on major conditions such as acute myocardial infarction, acute coronary syndrome, atrial fibrillation, and chronic heart failure. This work is aimed at testing new ways to prevent complications, improve heart protection, and support better recovery after serious cardiac events.

  • Prevention of stroke and systemic embolism in atrial fibrillation
  • Reducing recurrent events after myocardial infarction
  • Improving treatment for heart failure with reduced ejection fraction
  • Evaluating therapies for urgent bleeding control and surgical safety

These studies reflect a strong clinical focus on safer, more effective treatment strategies for patients with high-risk heart and blood vessel conditions.

Oncology and Hematology Trials

The site is active in neoplasms and hemic and lymphatic diseases, with research spanning breast cancer, lung cancer, renal cell carcinoma, lymphoma, multiple myeloma, and myelodysplastic syndrome. These trials are generally designed to compare new treatment approaches with current standards and to improve disease control and survival.

  • Advancing care in diffuse large B-cell lymphoma and follicular lymphoma
  • Testing new options for advanced breast cancer and early breast cancer
  • Evaluating therapies for multiple myeloma and myelodysplastic syndrome
  • Studying treatment effectiveness in small cell lung cancer and non-small cell lung cancer

This research supports ongoing efforts to improve outcomes for patients with difficult-to-treat blood cancers and solid tumors.

Respiratory and Allergy Medicine

Research in respiratory tract diseases includes asthma, chronic obstructive pulmonary disease, and respiratory syncytial virus prevention. The trials aim to reduce exacerbations, lower dependence on existing medicines, and strengthen protection for vulnerable groups.

  • Improving control of severe eosinophilic asthma
  • Reducing flare-ups in oral corticosteroid-dependent asthma
  • Testing long-term management approaches for COPD
  • Supporting prevention of RSV infection in high-risk infants and children

At the Internal Cardiology Clinic, these studies add to a broader portfolio that combines chronic disease management with prevention-focused care.

Immune-Mediated and Inflammatory Diseases

Several trials address immune system diseases and inflammatory disorders such as psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and psoriasis. The main goal is to evaluate therapies that may better control symptoms, reduce inflammation, and improve daily functioning.

  • Studying treatment options for psoriatic arthritis and related joint disease
  • Evaluating care for moderate to severe chronic plaque psoriasis
  • Assessing therapies for juvenile idiopathic arthritis
  • Exploring improved control of chronic immune-driven inflammation

This area shows an emphasis on long-term symptom relief and better disease control for patients with persistent inflammatory conditions.

Neurology, Psychiatry, and Imaging Research

Clinical activity also includes nervous system diseases, multiple sclerosis, myasthenia gravis, psychoses, and imaging-related diagnostic studies. These trials are designed to improve treatment options, better understand disease behavior, and refine diagnostic evaluation.

  • Assessing long-term management in multiple sclerosis
  • Evaluating therapy for generalized myasthenia gravis
  • Studying genetic and treatment-related factors in psychosis
  • Improving magnetic resonance imaging contrast use for diagnostic assessment

These studies highlight a balanced interest in both advanced treatment and better diagnostic tools for complex neurological and psychiatric conditions.

Other Specialized Clinical Research

The trial portfolio also includes female urogenital diseases, virus diseases, and blood disorders such as haemophilia A, alongside conditions like endometriosis and uveitic macular edema. Research here often focuses on symptom relief, safety, and improved quality of life.

  • Investigating treatment for endometriosis-related pain
  • Studying prevention and management in haemophilia A
  • Evaluating care for uveitic macular edema
  • Exploring protection against viral infections in at-risk populations

Across these diverse studies, Fakultni Nemocnice Brno supports clinical research aimed at practical improvements in diagnosis, prevention, and treatment.

Site Overview

assignment
363
connected trials
corporate_fare
142
sponsors
science
498
IMPs

Activity Indicator

Last 6 months

36
Trials started
+6% vs previous period.
34
Trials started 6–12 months ago
363
Total trials linked
Highly Active
trending_upGrowing+6%
4
10
10
5
6
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 25 therapeutic areas and 15 of 498 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 469 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
168
Sponsors (total)
142
Active sponsors
98

Sponsor Network

Top 98 by active trials.

lock +97 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +45 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
363
Outperforms 100% of sites
public
Therapeutic diversity
25areas
Outperforms 99% of sites
groups
Sponsor diversity
142sponsors
Outperforms 100% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Fakultni Nemocnice Brno

lock Showing 1 of 363 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 498 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Dexamethasone38Unknown2017-10-022026-07-28

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.